dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments Launches Oral Semaglutide in India: A Major Boost for Care Evolution of GLP‐1 Receptor Agonists
Description
The goal is not to push or avoid medication, but to ensure that any approach is safe, informed, and aligned with overall health

Medicare GLP-1 Bridge: A new federal demonstration program now provides select Medicare Part D beneficiaries access to Wegovy and Zepbound for a flat $50 monthly copayment , provided they meet specific medical criteria

Back Bloom, Stephen, email to Lara Marks, 17 Dec 2024

Patient preference data showing a strong bias towards oral therapies over injections 7,8 points to a broader redefinition of engagement, adherence and long-term management

The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE -/- and LDLr -/- mice by a mechanism that includes inflammatory pathways

Accessed 2025 Apr 25
